User menu

Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis.

Bibliographic reference Tamirou, Farah ; D'Cruz, David ; Sangle, Shirish ; Remy, Philippe ; Vasconcelos, Carlos ; et. al. Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis.. In: Annals of the Rheumatic Diseases, Vol. 75, no. 3, p. 526-531 (2016)
Permanent URL http://hdl.handle.net/2078.1/169059
  1. Hahn Bevra H., McMahon Maureen A., Wilkinson Alan, Wallace W. Dean, Daikh David I., FitzGerald John D., Karpouzas George A., Merrill Joan T., Wallace Daniel J., Yazdany Jinoos, Ramsey-Goldman Rosalind, Singh Karandeep, Khalighi Mazdak, Choi Soo-In, Gogia Maneesh, Kafaja Suzanne, Kamgar Mohammad, Lau Christine, Martin William J., Parikh Sefali, Peng Justin, Rastogi Anjay, Chen Weiling, Grossman Jennifer M., American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis, 10.1002/acr.21664
  2. Bertsias George K, Tektonidou Maria, Amoura Zahir, Aringer Martin, Bajema Ingeborg, Berden Jo H M, Boletis John, Cervera Ricard, Dörner Thomas, Doria Andrea, Ferrario Franco, Floege Jürgen, Houssiau Frederic A, Ioannidis John P A, Isenberg David A, Kallenberg Cees G M, Lightstone Liz, Marks Stephen D, Martini Alberto, Moroni Gabriela, Neumann Irmgard, Praga Manuel, Schneider Matthias, Starra Argyre, Tesar Vladimir, Vasconcelos Carlos, van Vollenhoven Ronald F, Zakharova Helena, Haubitz Marion, Gordon Caroline, Jayne David, Boumpas Dimitrios T, Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis, 10.1136/annrheumdis-2012-201940
  3. Bose Bhadran, Silverman Earl D., Bargman Joanne M., Ten Common Mistakes in the Management of Lupus Nephritis, 10.1053/j.ajkd.2013.10.056
  4. Furie Richard, Nicholls Kathy, Cheng Tien-Tsai, Houssiau Frederic, Burgos-Vargas Ruben, Chen Shun-Le, Hillson Jan L., Meadows-Shropshire Stephanie, Kinaszczuk Michael, Merrill Joan T., Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve-Month, Randomized, Double-Blind Study : Abatacept in Lupus Nephritis, 10.1002/art.38260
  5. Rovin Brad H., Furie Richard, Latinis Kevin, Looney R. John, Fervenza Fernando C., Sanchez-Guerrero Jorge, Maciuca Romeo, Zhang David, Garg Jay P., Brunetta Paul, Appel Gerald, , Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study, 10.1002/art.34359
  6. Mosca M., Tani C., Aringer M., Bombardieri S., Boumpas D., Brey R., Cervera R., Doria A., Jayne D., Khamashta M. A., Kuhn A., Gordon C., Petri M., Rekvig O. P., Schneider M., Sherer Y., Shoenfeld Y., Smolen J. S., Talarico R., Tincani A., van Vollenhoven R. F., Ward M. M., Werth V. P., Carmona L., European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies, 10.1136/ard.2009.117200
  7. , Liang Matthew H., Schur Peter H., Fortin Paul, St.Clair E. William, Balow James E., Costenbader Karen, Crofford Leslie, Pablo Paola de, Dooley Mary Anne, Finckh Axel, Gordon Caroline P., Lundberg Ingrid E., Meyrier Alain, Nived Ola, Ponticelli Claudio, Schneider Matthias K., Singh Ajay, Wallace Daniel J., The American college of rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials, 10.1002/art.21625
  8. Houssiau F A, Vasconcelos C, D'Cruz D, Sebastiani G D, de Ramon Garrido E, Danieli M G, Abramovicz D, Blockmans D, Cauli A, Direskeneli H, Galeazzi M, Gul A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico R A, Cattaneo R, Font J, Depresseux G, Cosyns J-P, Cervera R, The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide, 10.1136/ard.2008.102533
  9. Houssiau Frédéric A., Vasconcelos Carlos, D'Cruz David, Sebastiani Gian Domenico, de Ramon Garrido Enrique, Danieli Maria Giovanna, Abramovicz Daniel, Blockmans Daniel, Mathieu Alessandro, Direskeneli Haner, Galeazzi Mauro, Gül Ahmet, Levy Yair, Petera Peter, Popovic Rajko, Petrovic Radmila, Sinico Renato Alberto, Cattaneo Roberto, Font Josep, Depresseux Geneviève, Cosyns Jean-Pierre, Cervera Ricard, Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial : Early Response to Treatment Predicts Good Outcome in Lupus Nephritis, 10.1002/art.20666
  10. Feng Li, Deng Jin, Huo Dong-Mei, Wu Qiao-Yuan, Liao Yun-Hua, Mycophenolate mofetilversusazathioprine as maintenance therapy for lupus nephritis: A meta-analysis : MMF and AZA in lupus nephritis, 10.1111/nep.12006
  11. Maneiro Jose R., Lopez-Canoa Nicolas, Salgado Eva, Gomez-Reino Juan J., Maintenance therapy of lupus nephritis with mycophenolate or azathioprine: systematic review and meta-analysis, 10.1093/rheumatology/ket429
  12. Henderson Lorna K., Masson Philip, Craig Jonathan C., Roberts Matthew A., Flanc Robert S., Strippoli Giovanni F.M., Webster Angela C., Induction and Maintenance Treatment of Proliferative Lupus Nephritis: A Meta-analysis of Randomized Controlled Trials, 10.1053/j.ajkd.2012.08.041
  13. Stoenoiu M. S., Aydin S., Tektonidou M., Ravelingien I., le Guern V., Fiehn C., Remy P., Delahousse M., Petera P., Quemeneur T., Vasconcelos C., D'Cruz D., Gilboe I.-M., Jadoul M., Karras A., Depresseux G., Guillevin L., Cervera R., Cosyns J.-P., Houssiau F. A., , Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial, 10.1093/ndt/gfr553
  14. Contreras Gabriel, Pardo Victoriano, Leclercq Baudouin, Lenz Oliver, Tozman Elaine, O'Nan Patricia, Roth David, Sequential Therapies for Proliferative Lupus Nephritis, 10.1056/nejmoa031855
  15. Austin Howard A., Klippel John H., Balow James E., Le Riche Nicole G.H., Steinberg Alfred D., Plotz Paul H., Decker John L., Therapy of Lupus Nephritis, 10.1056/nejm198603063141004
  16. Houssiau Frédéric A., Biologic Therapy in Lupus Nephritis, 10.1159/000368587
  17. Condon Marie B, Ashby Damien, Pepper Ruth J, Cook H Terence, Levy Jeremy B, Griffith Megan, Cairns Tom D, Lightstone Liz, Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids, 10.1136/annrheumdis-2012-202844
  18. Rovin B. H., Parikh S. V., Hebert L. A., Chan T. M., Mok C. C., Ginzler E. M., Hooi L. S., Brunetta P., Maciuca R., Solomons N., Lupus Nephritis: Induction Therapy in Severe Lupus Nephritis--Should MMF Be Considered the Drug of Choice?, 10.2215/cjn.03290412
  19. ONG LOKE MENG, HOOI LAI SEONG, LIM TECK ONN, GOH BAK LEONG, AHMAD GHAZALI, GHAZALLI ROZINA, TEO SUE MEI, WONG HIN SENG, TAN SI YEN, SHAARIAH WAN, TAN CHWEE CHOON, MORAD ZAKI, Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis, 10.1111/j.1440-1797.2005.00444.x
  20. Appel G. B., Contreras G., Dooley M. A., Ginzler E. M., Isenberg D., Jayne D., Li L.-S., Mysler E., Sanchez-Guerrero J., Solomons N., Wofsy D., , Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis, 10.1681/asn.2008101028
  21. Ginzler Ellen M., Dooley Mary Anne, Aranow Cynthia, Kim Mimi Y., Buyon Jill, Merrill Joan T., Petri Michelle, Gilkeson Gary S., Wallace Daniel J., Weisman Michael H., Appel Gerald B., Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis, 10.1056/nejmoa043731
  22. Houssiau Frédéric A, Therapy of lupus nephritis: lessons learned from clinical research and daily care of patients, 10.1186/ar3656
  23. Tan Eng M., Cohen Alan S., Fries James F., Masi Alfonse T., Mcshane Dennis J., Rothfield Naomi F., Schaller Jane Green, Talal Norman, Winchester Robert J., The 1982 revised criteria for the classification of systemic lupus erythematosus : REVISED CRITERIA FOR SLE, 10.1002/art.1780251101
  24. Houssiau Frédéric A., Vasconcelos Carlos, D'Cruz David, Sebastiani Gian Domenico, Garrido Enrique de Ramon, Danieli Maria Giovanna, Abramovicz Daniel, Blockmans Daniel, Mathieu Alessandro, Direskeneli Haner, Galeazzi Mauro, Gül Ahmet, Levy Yair, Petera Peter, Popovic Rajko, Petrovic Radmila, Sinico Renato Alberto, Cattaneo Roberto, Font Josep, Depresseux Geneviève, Cosyns Jean-Pierre, Cervera Ricard, Immunosuppressive therapy in lupus nephritis: The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide : Immunosuppressive Therapy in Lupus Nephritis, 10.1002/art.10461
  25. Houssiau F. A., D'Cruz D., Sangle S., Remy P., Vasconcelos C., Petrovic R., Fiehn C., de Ramon Garrido E., Gilboe I.-M., Tektonidou M., Blockmans D., Ravelingien I., le Guern V., Depresseux G., Guillevin L., Cervera R., , Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial, 10.1136/ard.2010.131995
  26. Dooley Mary Anne, Jayne David, Ginzler Ellen M., Isenberg David, Olsen Nancy J., Wofsy David, Eitner Frank, Appel Gerald B., Contreras Gabriel, Lisk Laura, Solomons Neil, Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis, 10.1056/nejmoa1014460
  27. THAMER M., HERNAN M. A., ZHANG Y., COTTER D., PETRI M., Prednisone, Lupus Activity, and Permanent Organ Damage, 10.3899/jrheum.080828
  28. Gladman, J Rheumatol, 30, 1955 (2003)
  29. El Hachmi M, Jadoul M, Lefebvre C, Depresseux G, Houssiau F A, Relapses of lupus nephritis: incidence, risk factors, serology and impact on outcome, 10.1191/0961203303lu444oa